open access

Vol 79, No 11 (2008)
ARTICLES
Get Citation

The influence of a tibolone therapy on endometrium in postmenopausal women

Stanisław Radowicki, Waldemar Wierzba, Katarzyna Szlendak-Sauer
Ginekol Pol 2008;79(11).

open access

Vol 79, No 11 (2008)
ARTICLES

Abstract

Objective: Assessment of the frequency of vaginal bleeding and morphologic changes of endometrium in postmenopausal women treated with tibolone. Material: 26 patients, aged from 50 to 70 (mean 59.7+/-6.7) years, without contraindications to hormonal replacement therapy. Methods: The therapy with a tibolone in a daily dose of 2.5mg during the course of 1 year. The assessment of endometrium was obtained by means of transvaginal ultrasound examination (USG TV) and curratage and/or biopsy with Pipelle probe. Results: during the therapy with tibolone, vaginal bleeding was noted in case of 3 (11.5%) postmenopausal women. The thickness of endometrium measured by USG TV was mean 4.6}2.3mm and did not change enough to be considered statistically significant during the therapy. Endometrial morphology assessed by curratage and/or biopsy showed atrophic endometrium in 20 patients, polyposis endometrium in 1 case or no samples. Conclusions: Tibolone therapy leads to low rates of vaginal bleeding and atrophic changes of the endometrium. Tibolone is a safe and effective alternative to hormonal therapy in postmenopausal women.

Abstract

Objective: Assessment of the frequency of vaginal bleeding and morphologic changes of endometrium in postmenopausal women treated with tibolone. Material: 26 patients, aged from 50 to 70 (mean 59.7+/-6.7) years, without contraindications to hormonal replacement therapy. Methods: The therapy with a tibolone in a daily dose of 2.5mg during the course of 1 year. The assessment of endometrium was obtained by means of transvaginal ultrasound examination (USG TV) and curratage and/or biopsy with Pipelle probe. Results: during the therapy with tibolone, vaginal bleeding was noted in case of 3 (11.5%) postmenopausal women. The thickness of endometrium measured by USG TV was mean 4.6}2.3mm and did not change enough to be considered statistically significant during the therapy. Endometrial morphology assessed by curratage and/or biopsy showed atrophic endometrium in 20 patients, polyposis endometrium in 1 case or no samples. Conclusions: Tibolone therapy leads to low rates of vaginal bleeding and atrophic changes of the endometrium. Tibolone is a safe and effective alternative to hormonal therapy in postmenopausal women.
Get Citation

Keywords

hormone replacement therapy, tibolone

About this article
Title

The influence of a tibolone therapy on endometrium in postmenopausal women

Journal

Ginekologia Polska

Issue

Vol 79, No 11 (2008)

Bibliographic record

Ginekol Pol 2008;79(11).

Keywords

hormone replacement therapy
tibolone

Authors

Stanisław Radowicki
Waldemar Wierzba
Katarzyna Szlendak-Sauer

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl